Literature DB >> 21450639

Repeat six-minute walk tests in patients with chronic heart failure: are they clinically necessary?

Julie Adsett1, Robert Mullins, Rita Hwang, Amy Hogden, Ellen Gibson, Kylie Houlihan, Michael Tuppin, Dariusz Korczyk, Kylie-Ann Mallitt, Alison Mudge.   

Abstract

BACKGROUND: Owing to a reported learning effect in patients with chronic cardiopulmonary disease, performance of at least two six-minute walk tests (6MWT) are recommended as standard practice. Patients with chronic heart failure (CHF) are typically elderly and frail and it is unknown whether current guidelines are practical in a clinical setting. AIMS: The aim of this study was to determine whether repeat performance of 6MWTs in patients with CHF is related to between-test interval or baseline performance.
METHODS: This was a multisite observational study enrolling participants entering into heart failure rehabilitation programmes. Participants performed two 6MWTs with randomly allocated inter-test intervals between 15 and 90 minutes. Distance walked in the second test was compared with the first test using a paired t test.
RESULTS: Eighty-eight participants (45 females, age 65 ± 14 years) with stable CHF were enrolled. Mean distance walked increased from 301 metres in test 1 to 313 metres in test 2 (p < 0.001). No significant change was recorded between test 1 and test 2 for those whose baseline distance was <300 metres. The interval between tests had no significant effect on the distance walked.
CONCLUSION: The change in 6MWT distance was significantly associated with better baseline performance but not with the interval between tests.

Entities:  

Mesh:

Year:  2011        PMID: 21450639     DOI: 10.1177/1741826710389403

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  5 in total

1.  Is there a learning effect when the 6-minute walk test is repeated in people with suspected pulmonary hypertension?

Authors:  Lissa Spencer; Bill Zafiropoulos; Wendy Denniss; Dot Fowler; Jennifer Alison; David Celermajer
Journal:  Chron Respir Dis       Date:  2018-01-23       Impact factor: 2.444

2.  Prognostic impact of 6 min walk test distance in patients with systolic heart failure: insights from the WARCEF trial.

Authors:  Kenji Matsumoto; Yi Xiao; Shunichi Homma; John L P Thompson; Richard Buchsbaum; Kazato Ito; Stefan D Anker; Min Qian; Marco R Di Tullio
Journal:  ESC Heart Fail       Date:  2020-12-30

3.  Intravenous iron supplement for iron deficiency in patients with severe aortic stenosis scheduled for transcatheter aortic valve implantation: results of the IIISAS randomised trial.

Authors:  Anette B Kvaslerud; Sara Bardan; Kristoffer Andresen; Sophie F Kløve; Morten W Fagerland; Thor Edvardsen; Lars Gullestad; Kaspar Broch
Journal:  Eur J Heart Fail       Date:  2022-06-03       Impact factor: 17.349

4.  Reference Value for the Distance Walked in the Six-Minute Walk Test in Obese Brazilian Men in the Preoperative Period of Bariatric Surgery.

Authors:  Cesar Antonio Luchesa; Thiago Thomaz Mafort; Rafael Rodrigues da Silva; Isabela Cristina Paro; Fernanda Micheli de Souza; Agnaldo José Lopes
Journal:  J Obes       Date:  2021-07-08

5.  Effect of a 6-month pedometer-based walking intervention on functional capacity in patients with chronic heart failure with reduced (HFrEF) and with preserved (HFpEF) ejection fraction: study protocol for two multicenter randomized controlled trials.

Authors:  Tomas Vetrovsky; Michal Siranec; Jiri Parenica; Martin Griva; Jiri Stastny; Jan Precek; Radek Pelouch; Vaclav Bunc; Ales Linhart; Jan Belohlavek
Journal:  J Transl Med       Date:  2017-07-03       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.